About EndoChoice
EndoChoice is a company based in Alpharetta (United States) founded in 2008 was acquired by Boston Scientific in September 2016. EndoChoice has raised $115.96 million across 7 funding rounds from investors including Boston Scientific, SVB and MidCap Financial. The company has 414 employees as of December 31, 2016. EndoChoice has completed 1 acquisition, including Peer Medical. EndoChoice operates in a competitive market with competitors including EndoGastric Solutions, CoapTech, SafeStitch, Endo Tools Therapeutics and EndoStim, among others.
- Headquarter Alpharetta, United States
- Employees 414 as on 31 Dec, 2016
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Endochoice Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$115.96 M (USD)
in 7 rounds
-
Latest Funding Round
$58 M (USD), Debt – Conventional
Jun 30, 2015
-
Investors
Boston Scientific
& 9 more
-
Employee Count
414
as on Dec 31, 2016
- Investments & Acquisitions
-
Acquired by
Boston Scientific
(Sep 27, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of EndoChoice
EndoChoice has successfully raised a total of $115.96M across 7 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $58 million completed in June 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in EndoChoice
EndoChoice has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Boston Scientific, SVB and MidCap Financial.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private debt funds are managed across multiple sectors.
|
Locked | Locked | Locked | |
|
Early-stage and late-stage biotech and finance companies are funded.
|
Locked | Locked | Locked | |
|
Sequoia Capital is engaged in venture capital investments.
|
Locked | Locked | Locked |
Investor details for EndoChoice
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by EndoChoice
EndoChoice has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Peer Medical.
Investment portfolio details for EndoChoice
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Gastrointestinal endoscopy technology for bowel cancer diagnosis was developed.
|
Locked | Locked | 2009 | Locked |
Complete acquisition details for EndoChoice
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - EndoChoice
Detailed financials for EndoChoice
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Endochoice Comparisons
Peer comparison for EndoChoice
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of EndoChoice
EndoChoice operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EndoGastric Solutions, CoapTech, SafeStitch, Endo Tools Therapeutics and EndoStim, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Incisionless transoral procedures for upper GI diseases are developed.
|
|
| Locked | Locked | Locked |
Minimally invasive gastrostomy feeding tube placement method is developed.
|
|
| Locked | Locked | Locked |
Medical devices for gastrointestinal and bariatric surgery are developed.
|
|
| Locked | Locked | Locked |
Endoscopic catheters for precision in gastroenterology are developed.
|
|
| Locked | Locked | Locked |
Implant to treat GERD
|
Detailed competitors of EndoChoice
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Endochoice
Complete news archive for EndoChoice
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EndoChoice
EndoChoice was founded in 2008.
EndoChoice is headquartered in Alpharetta, United States. It is registered at Alpharetta, Georgia, United States.
EndoChoice is a funded company, having raised a total of $115.96M across 7 funding rounds to date.
As of Dec 31, 2016, the latest employee count at EndoChoice is 414.
EndoChoice was founded in 2008 and is based in Alpharetta, United States. Operations focus on the gastrointestinal sector, where devices, diagnostics, infection control measures, and imaging tools are supplied to specialists addressing GI conditions. A public listing on the stock exchange was completed in June 2015, supporting expansion in medical technology for digestive health.
EndoChoice's top competitors include CoapTech, Endo Tools Therapeutics and EndoGastric Solutions.
EndoChoice has made 1 acquisition, including Peer Medical.
EndoChoice has 10 investors. Key investors include Boston Scientific, SVB, MidCap Financial, Rock Springs Capital, and Sequoia Capital.